Heart Failure Life Expectancy Calculator
Estimate survival probability in heart failure using the Seattle Heart Failure Model framework. Incorporates NYHA class, ejection fraction, medications, lab values, and device therapy to project 1-3 year survival.
Did our AI summary help? Let us know.
Key values and context for this tool: • NYHA Classes: I-IV • 5-Year Survival: ~50% • HF Prevalence: 6.7M US
Ready to run the numbers?
Why: Heart failure affects 6.7 million Americans with highly variable prognosis. Risk stratification helps guide treatment intensity, device therapy decisions, and advance care planning.
How: Enter NYHA class, ejection fraction, age, key labs (sodium, hemoglobin, creatinine), medications, and device therapy to estimate survival curves.
Run the calculator when you are ready.
For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.
Heart Failure Overview
Heart failure affects 6.7 million Americans with 5-year mortality of ~50%. Prognosis varies by ejection fraction (HFrEF vs HFpEF), NYHA class, age, and guideline-directed medical therapy. Early optimization improves outcomes.
NYHA Classification
Class I
No limitation of physical activity.
Class II
Slight limitation with ordinary activity.
Class III
Marked limitation with less than ordinary activity.
Class IV
Symptoms at rest.
MAGGIC Risk Score
The MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) score combines age, gender, BMI, ejection fraction, NYHA class, creatinine, systolic BP, diabetes, COPD, and medication use. Higher scores indicate worse prognosis. Validated in multiple cohorts.
Seattle Heart Failure Model
The Seattle HF Model predicts 1-, 2-, and 5-year survival. It incorporates medications (ACEi, beta-blockers, statins), devices (ICD, CRT), and biomarkers. Used for transplant listing and shared decision-making.
Guideline-Directed Medical Therapy
- ACE inhibitors or ARBs (or ARNI)
- Evidence-based beta-blockers
- Mineralocorticoid receptor antagonists
- SGLT2 inhibitors (dapagliflozin, empagliflozin)
- ICD for primary prevention (EF ≤35%)
- CRT for LBBB and wide QRS
Ejection Fraction Types
HFrEF (EF <40%): Reduced EF, generally worse prognosis without therapy. HFmrEF (40-49%): Mid-range. HFpEF (≥50%): Preserved EF, different pathophysiology, often elderly with comorbidities.
Treatment Impact
GDMT reduces mortality by 30-40% in HFrEF. Each pillar (ACEi, BB, MRA, SGLT2i) adds incremental benefit. Device therapy (ICD, CRT) further reduces sudden death and hospitalization.
Sources
- Seattle Heart Failure Model
- ACC/AHA Heart Failure Guidelines
- MAGGIC Risk Score
- ESC Heart Failure Guidelines
FAQ
What are heart failure stages?
ACC/AHA stages A-D: A = risk factors only; B = structural disease, no symptoms; C = prior/current HF symptoms; D = refractory HF. Stage correlates with prognosis and treatment intensity.
What are NYHA classes?
NYHA I: No limitation. II: Slight limitation with ordinary activity. III: Marked limitation with less than ordinary activity. IV: Symptoms at rest. Class correlates strongly with prognosis.
How do I interpret EF (HFrEF vs HFpEF)?
HFrEF: EF <40%, reduced ejection fraction, generally worse prognosis without therapy. HFpEF: EF ≥50%, preserved EF, different pathophysiology, often elderly with comorbidities.
What factors affect heart failure prognosis?
Age, EF, NYHA class, creatinine, sodium, hemoglobin, BMI, diabetes, COPD, and guideline-directed medical therapy. Lower EF and higher NYHA class predict worse outcomes.
How does treatment impact survival?
GDMT (ACEi/ARNI, beta-blockers, MRAs, SGLT2i) reduces mortality 30-40% in HFrEF. Each pillar adds incremental benefit. ICD and CRT further reduce sudden death and hospitalization.
When to consider advanced therapies?
Consider ICD for EF ≤35% on GDMT; CRT for LBBB and wide QRS. Advanced HF (NYHA III-IV) may warrant LVAD or transplant evaluation. Shared decision-making is essential.
Disclaimer
This calculator is for educational purposes only. It does not replace professional medical advice. Discuss prognosis and treatment with your cardiologist or heart failure specialist.
Related Calculators
Advanced TIMI Score for STEMI Calculator
Comprehensive TIMI risk score calculator for ST-elevation myocardial infarction with enhanced clinical decision support, multiple validation studies, risk...
HealthPERC Calculator - Pulmonary Embolism Rule-Out Criteria
Advanced PERC (Pulmonary Embolism Rule-out Criteria) calculator with comprehensive clinical decision support, Wells Score integration, age-specific...
HealthPISA Calculator - Proximal Isovelocity Surface Area
Advanced PISA (Proximal Isovelocity Surface Area) calculator for comprehensive mitral valve assessment with multiple calculation methods (Standard PISA, 3D...
HealthAdvanced Stroke Volume Calculator
Comprehensive stroke volume calculator with multiple calculation methods (EDV-ESV, CO/HR, Doppler echo), advanced hemodynamic analysis, clinical decision...
HealthAdvanced STOP-BANG Calculator
Professional-grade STOP-BANG questionnaire for sleep apnea risk assessment with weighted scoring, clinical decision support, AHI predictions, treatment...
HealthCVD Risk Calculator - Cardiovascular Disease Risk Assessment
Advanced cardiovascular disease risk calculator with multiple validated models (Framingham, PREVENT, ASCVD, QRISK3), 10-year and 30-year risk projections...
Health